GARUTI, ANNA
 Distribuzione geografica
Continente #
EU - Europa 8.235
NA - Nord America 910
AS - Asia 839
Continente sconosciuto - Info sul continente non disponibili 93
SA - Sud America 86
AF - Africa 18
OC - Oceania 5
Totale 10.186
Nazione #
IT - Italia 8.065
US - Stati Uniti d'America 865
SG - Singapore 307
CN - Cina 212
VN - Vietnam 166
BD - Bangladesh 69
FR - Francia 62
BR - Brasile 50
HK - Hong Kong 28
DE - Germania 25
AR - Argentina 23
CA - Canada 18
FI - Finlandia 14
GB - Regno Unito 13
IQ - Iraq 11
JP - Giappone 11
IN - India 10
ES - Italia 9
MX - Messico 7
NL - Olanda 7
UA - Ucraina 7
CH - Svizzera 6
RU - Federazione Russa 6
EC - Ecuador 5
ID - Indonesia 5
AU - Australia 4
CO - Colombia 4
CR - Costa Rica 4
IE - Irlanda 4
SE - Svezia 4
SV - El Salvador 4
ZA - Sudafrica 4
HN - Honduras 3
TR - Turchia 3
UZ - Uzbekistan 3
AL - Albania 2
JM - Giamaica 2
KE - Kenya 2
MA - Marocco 2
NG - Nigeria 2
NP - Nepal 2
PA - Panama 2
PK - Pakistan 2
RS - Serbia 2
SA - Arabia Saudita 2
SC - Seychelles 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
VE - Venezuela 2
AM - Armenia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BE - Belgio 1
BG - Bulgaria 1
BH - Bahrain 1
CI - Costa d'Avorio 1
DK - Danimarca 1
EG - Egitto 1
ET - Etiopia 1
GH - Ghana 1
GR - Grecia 1
GT - Guatemala 1
JO - Giordania 1
KY - Cayman, isole 1
KZ - Kazakistan 1
LT - Lituania 1
MD - Moldavia 1
NI - Nicaragua 1
OM - Oman 1
PE - Perù 1
PF - Polinesia Francese 1
PH - Filippine 1
PT - Portogallo 1
PY - Paraguay 1
SI - Slovenia 1
SY - Repubblica araba siriana 1
Totale 10.093
Città #
Genova 4.762
Genoa 2.020
Rapallo 731
Vado Ligure 479
San Jose 210
Ashburn 136
Singapore 130
Lauterbourg 53
Beijing 47
Ho Chi Minh City 47
New York 33
Hanoi 28
Hong Kong 27
Los Angeles 26
Council Bluffs 25
Frankfurt am Main 23
Santa Clara 21
Chicago 18
Helsinki 14
Da Nang 12
Phoenix 12
Bordighera 11
Haiphong 11
Naples 10
Tokyo 10
Dallas 9
Milan 8
Atlanta 7
Kyiv 6
Orem 6
Rome 6
Zurich 6
Amsterdam 5
Biên Hòa 5
Charlotte 5
Paris 5
Buenos Aires 4
Buffalo 4
Cardiff 4
London 4
Montreal 4
San Francisco 4
Stockholm 4
São Paulo 4
The Bronx 4
Tianjin 4
Turin 4
Baghdad 3
Birmingham 3
Brooklyn 3
Bắc Giang 3
Can Tho 3
Detroit 3
Dublin 3
Jacksonville 3
Johannesburg 3
Madrid 3
Mexico City 3
Miami 3
Rio de Janeiro 3
San Bernardino 3
San Salvador 3
Secaucus 3
Sydney 3
Thái Bình 3
Washington 3
Anaheim 2
Ankara 2
Arlington Heights 2
Bossier City 2
Boydton 2
Cagliari 2
Catania 2
Chennai 2
Davenport 2
Denver 2
Des Moines 2
Dhaka 2
Draper 2
Erie 2
Guayaquil 2
Hohenwald 2
Houston 2
Hải Dương 2
Iowa City 2
Karbala 2
Kissimmee 2
Lansdowne 2
Memphis 2
Milwaukee 2
Mobile 2
Nairobi 2
New Haven 2
New Orleans 2
Newark 2
Nha Trang 2
Panama City 2
Philadelphia 2
Porto Alegre 2
Prosper 2
Totale 9.133
Nome #
APO866 increases antitumor activity of cyclosporin - A by inducing mitochondrial and endoplasmic reticulum stress in leukemia cells 328
APO866 activity in hematologic malignancies: a preclinical in vitro study. 256
Grb7 upregulation is a molecular adaptation to HER2 signaling inhibition due to removal of AKT-mediated gene repression 254
Catastrophic NAD(+) Depletion in Activated T Lymphocytes through Nampt Inhibition Reduces Demyelination and Disability in EAE 230
Uncovering the genomic heterogeneity of multifocal breast cancer 215
Inhibition of Nicotinamide Phosphoribosyltransferase Reduces Neutrophil-Mediated Injury in Myocardial Infarction. 213
A new human calpastatin skipped of the inhibitory region protects calpain-1 from inactivation and degradation 212
Abstract 49: Agreement of immunohistochemistry, fluorescence in situ hybridization, real-time quantitative polymerase-chain reaction, and quantitative reverse transcriptase PCR for Her-2/Neu status assessment in breast cancer patients: a single center, retrospective m 211
Ras-induced resistance to lapatinib is overcome by MEK inhibition 210
Reverse-transcriptase polymerase chain reaction of the maspin gene in the detection of bone marrow breast carcinoma cell contamination. 207
ANTITUMOR ACTIVITY OF NAMPT INHIBITION AND SYNERGY WITH CYCLOSPORIN A AND HDACIS TO PROMOTE APOPTOSIS IN PRIMARY LEUKEMIC CELLS 206
High-dose chemotherapy with tandem autologous transplantation as part of the initial therapy for aggressive non-Hodgkin's lymphoma 201
Moderate increase of indoxyl sulfate promotes monocyte transition into profibrotic macrophages 200
Molecular diagnosis and monitoring of chronic myelogenous leukemia: BCR-Abl and more. 198
Effect of different cytokines on mammaglobin and maspin gene expression in normal leukocytes. possible relevance to the assays for the detection of micrometastatic breast cancer 196
Comparative effects of three cytokine regimens after high-dose cyclophosphamide: granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor (GM-CSF), and sequential interleukin-3 and GM-CSF 195
Synergistic interactions between HDAC and sirtuin inhibitors in human leukemia cells. 193
Patient-tailored treatments with anti-EGFR monoclonal antibodies in advanced colorectal cancer: KRAS and beyond. 191
B-Amyloid 1-42 and RAGE play a key role in ATRA-induced neuronal differentiation 191
Clinico-pathological associations and concomitant mutations of the RAS/RAF pathway in metastatic colorectal cancer 191
Circulating tumor DNA using tagged targeted deep sequencing to assess minimal residual disease in breast cancer patients undergoing neoadjuvant chemotherapy 190
Peripheral blood vs. bone marrow for molecular monitoring of BCR-ABL1 levels in chronic myelogenous leukemia, a retrospective analysis in allogeneic bone marrow recipients. 186
Synergistic interactions between HDAC and sirtuin inhibitors in human leukemia cells 182
Effects of three cytokine regimens on hematologic recovery and progenitor cell mobilization after high-dose cyclophosphamide, etoposide, and cisplatin. 182
Tumor necrosis factor-related apoptosis-inducing ligand cooperates with anticancer drugs to overcome chemoresistance in antiapoptotic Bcl-2 family members expressing jurkat cells. 182
Anti-cancer activity of 5-O-alkyl 1,4-imino-1,4-dideoxyribitols. 181
Hedgehog Signaling Is Useful as a Novel Molecular Marker for Predicting Relapse and Resistance During Chronic Myeloid Leukemia Treatment 180
High ERp5/ADAM10 expression in lymph node microenvironment and impaired NKG2D ligands recognition in Hodgkin lymphomas. 179
The increased activity of BACE1 correlates with oxidative stress in Alzheimer’s disease. 178
Activation of the death receptor apoptosis pathway by TRAIL overcomes anticancer drug resisitance in antiapoptotic bcl-2 family members expressing lymphoma cells 177
High-dose mitoxantrone with peripheral blood progenitor cell rescue: toxicity, pharmacokinetics and implications for dosage and schedule 177
Squalene epoxidase is a bona fide oncogene by amplification with clinical relevance in breast cancer 177
Mutant presenilin 1 increases the expression and activity of BACE1. 175
Effective in vivo induction of NKG2D ligands in acute myeloid leukaemias by all-trans-retinoic acid or sodium valproate. 174
Dendritic cells transfected with tumor RNA for the induction of antitumor CTL in colorectal cancer 174
Three-step high-dose sequential chemotherapy in patients with newly diagnosed multiple myeloma 174
Catastrophic NAD+ Depletion through Nampt Inhibition in Activated T Lymphocytes Reduces Demyelination and Disability in EAE. 169
Proteasome inhibitor-induced apoptosis in human monocyte-derived dendritic cells. 168
Tracking molecular relapse of chronic myeloid leukemia by measuring Hedgehog signaling status 168
Evidence for a protective role of Mcl-1 in proteasome inhibitor-induced apoptosis 164
HDAC INHIBITORS SYNERGISTICALLY ENHANCE AP0866 ACTIVITY IN HUMAN LEUKEMIA CELLS: EVIDENCE FOR CONVERGING MECHANISMS OF SIRT1 INHIBITION 159
Germline mutations in the von Hippel-Lindau gene in Italian patients. 159
Optimization of a wga-free molecular tagging-based ngs protocol for ctcs mutational profiling 159
Upregulation of presenilin 1 in brains of sporadic, late-onset Alzheimer's disease 157
Novel 2-[(benzylamino)methyl]pyrrolidine-3,4-diol derivatives as alpha-mannosidase inhibitors and with antitumor activities against hematological and solid malignancies. 155
A T315I mutation in e19a2 BCR/ABL1 chronic myeloid leukemia responding to dasatinib 154
Reliability and reproducibility of a RNA preamplification method for low-density array analysis from formalin-fixed paraffin-embedded breast cancer samples. 143
Masked Philadelphia chromosome due to atypical BCR/ABL localization on the 9q34 band and duplication of the der(9) in a case of chronic myelogenous leukemia 139
Plasma Cell-Free DNA Integrity Assessed by Automated Electrophoresis Predicts the Achievement of Pathologic Complete Response to Neoadjuvant Chemotherapy in Patients with Breast Cancer 139
Depletion of the intracellular coenzyme NAD plus in activated T-cells ameliorates experimental autoimmune encephalomyelitis 130
Transcriptome Sequencing Of The Transition From Normal Epithelium To Invasive Cancer Reveals Insights Into The Carcinogenesis Of Hpv+ And Hpv- Vulvar Neoplasia 127
Mutational analysis of BRCA1 and BRCA2 genes in high grade serous ovarian carcinoma with Next Generation Sequencing (NGS); correlation between somatic and germline mutations 126
The role of alpha-interferon in chronic myelogenous leukaemia in imatinib era. 124
Potent Synergistic Activity of the NAD plus Synthesis Inhibitor APO866 and of the Apoptosis Inducer TRAIL in in Vitro and Ex Vivo Cellular Models of Non Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia. 118
β-amyloid 1-42 induces physiological transcriptional regulation of BACE1. 109
SLFN11 captures cancer-immunity interactions associated with platinum sensitivity in high-grade serous ovarian cancer 95
Targeting PIK3CA Actionable Mutations in the Circulome: A Proof of Concept in Metastatic Breast Cancer 89
LncRNA EPR regulates intestinal mucus production and protects against inflammation and tumorigenesis 69
Totale 10.186
Categoria #
all - tutte 31.900
article - articoli 30.635
book - libri 0
conference - conferenze 864
curatela - curatele 0
other - altro 401
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 63.800


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022702 0 0 66 110 28 50 52 168 34 63 46 85
2022/2023896 93 98 10 100 147 121 10 64 133 1 112 7
2023/2024487 20 53 4 69 33 98 19 38 19 18 37 79
2024/20251.307 47 85 43 90 151 110 116 278 37 51 137 162
2025/20262.316 297 63 118 159 354 164 344 118 181 238 146 134
2026/2027339 216 48 75 0 0 0 0 0 0 0 0 0
Totale 10.186